Feedback / Questions
emavusertib (CA-4948) - Curis, Dr. Reddy’s
https://www.prnewswire.com/news-releases/curis-announces-additional-encouraging-clinical-data-from-takeaim-leukemia-study-of-emavusertib-ca-4948-in-monotherapy-rr-aml-and-hrmds-301700033.html
Dec 12, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next